comparemela.com


St. Jude Children's Research Hospital, UTHSC assisting in local site.
Author: Brad Broders
Updated: 6:09 PM CST December 11, 2020
MEMPHIS, Tenn — As several COVID-19 vaccines inch closer to federal approval and mass distribution in the coming weeks, in the Mid-South Friday, local participants did their part in another vaccine trial now underway.
St. Jude and the University of Tennessee Health Science Center recently opened a site for Johnson & Johnson's Phase 3 trail of its COVID-19 vaccine candidate.
For one participant, it served a purpose beyond himself.
"At some point we've got to figure out what's best for the whole and not just individuals," Tony Milton, a vaccine participant, said.

Related Keywords

Tony Milton ,Johnson ,Jude Children Research Hospital ,University Of Tennessee Health Science Center ,Jude Children ,Research Hospital ,Mid South Friday ,Tennessee Health Science Center ,Aditya Gaur ,டோனி மில்டன் ,ஜான்சன் ,ஜூட் குழந்தைகள் ஆராய்ச்சி மருத்துவமனை ,பல்கலைக்கழகம் ஆஃப் டென்னசி ஆரோக்கியம் அறிவியல் மையம் ,ஜூட் குழந்தைகள் ,ஆராய்ச்சி மருத்துவமனை ,நடுவில் தெற்கு வெள்ளி ,டென்னசி ஆரோக்கியம் அறிவியல் மையம் ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.